Literature DB >> 14671707

Alternatives to the use of fetal bovine serum: serum-free cell culture.

Gerhard Gstraunthaler1.   

Abstract

Serum is commonly used as a supplement to cell culture media. It provides a broad spectrum of macromolecules, carrier proteins for lipoid substances and trace elements, attachment and spreading factors, low molecular weight nutrients, and hormones and growth factors. The most widely used animal serum supplement is fetal bovine serum, FBS. Since serum in general is an ill-defined component in cell culture media, a number of chemically defined serum-free media formulations have been developed in the last two decades. Besides modern cell biological advances in cell and tissue culture and efforts towards a standardisation of cell culture protocols in Good Cell Culture Practice, in addition, considerable ethical concerns were raised recently about the harvest and collection of fetal bovine serum. Thus, in order to decrease the annual need for bovine fetuses in terms of the 3Rs through any reduction in the use or partial replacement of serum, as well as in terms of an improvement of cell and tissue culture methodology, serum-free cell culture represents a modern, valuable and scientifically well accepted alternative to the use of FBS in cell and tissue culture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671707

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  87 in total

Review 1.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle.

Authors:  David K Krämer; Karim Bouzakri; Olle Holmqvist; Lubna Al-Khalili; Anna Krook
Journal:  Cytotechnology       Date:  2005-06       Impact factor: 2.058

3.  A plea to reduce or replace fetal bovine serum in cell culture media.

Authors:  Gerhard Gstraunthaler; Toni Lindl; Jan van der Valk
Journal:  Cytotechnology       Date:  2013-08-22       Impact factor: 2.058

Review 4.  Serum-free media for the production of human mesenchymal stromal cells: a review.

Authors:  S Gottipamula; M S Muttigi; U Kolkundkar; R N Seetharam
Journal:  Cell Prolif       Date:  2013-09-30       Impact factor: 6.831

Review 5.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

6.  Evaluation of royal jelly as an alternative to fetal bovine serum in cell culture using cell proliferation assays and live cell imaging.

Authors:  Marahaini Musa; Nurul Fatihah Mohamad Nasir; Kannan Ponnuraj Thirumulu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

7.  Cord blood serum harvesting by hydroxyethyl starch: a fetal bovine serum alternative in expansion of umbilical cord-derived mesenchymal stem cells.

Authors:  Maryam Samareh Salavati Pour; Reza Vahidi; Mahla Lashkari; Ali Derakhshani; Zahra Ameri; Alireza Farsinejad
Journal:  Cytotechnology       Date:  2020-06-29       Impact factor: 2.058

8.  Changes of the metabolism of the colon cancer cell line SW-480 under serum-free and serum-reduced growth conditions.

Authors:  Michelle Hartmann; Dunja Zimmermann; Jürgen Nolte
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-23       Impact factor: 2.416

9.  Feline Calicivirus, Murine Norovirus, Porcine Sapovirus, and Tulane Virus Survival on Postharvest Lettuce.

Authors:  Malak A Esseili; Linda J Saif; Tibor Farkas; Qiuhong Wang
Journal:  Appl Environ Microbiol       Date:  2015-05-22       Impact factor: 4.792

10.  Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum.

Authors:  Bettina Lindroos; Kaisa-Leena Aho; Hannu Kuokkanen; Sari Räty; Heini Huhtala; Riina Lemponen; Olli Yli-Harja; Riitta Suuronen; Susanna Miettinen
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.